Data gathered: January 6
AI Stock Analysis - PROCEPT BioRobotics (PRCT)
Analysis generated October 27, 2024. Powered by Chat GPT.
PROCEPT BioRobotics is a pioneering company in the field of surgical robotics. The company specializes in the development of innovative solutions for urological conditions, particularly through its flagship product, the Aquablation therapy. This robot-assisted procedure revolutionizes the treatment of benign prostatic hyperplasia (BPH), providing a minimally invasive option for patients. PROCEPT's unique technology has garnered significant attention and adoption in the medical community, positioning the company as a leader in its niche market.
Stock Alerts - PROCEPT BioRobotics (PRCT)
 |
PROCEPT BioRobotics | December 18 Price is down by -5.5% in the last 24h. |
|
PROCEPT BioRobotics | December 7 Insider Alert: Nouri Alaleh is selling shares |
|
PROCEPT BioRobotics | December 5 Price is down by -5.1% in the last 24h. |
|
PROCEPT BioRobotics | December 3 Insider Alert: Zadno Reza is selling shares |
Alternative Data for PROCEPT BioRobotics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 48 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 9,000 | Sign up | Sign up | Sign up |
| Google Trends | 11 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 799 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,304 | Sign up | Sign up | Sign up |
| Twitter Mentions | 17 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 660 | Sign up | Sign up | Sign up |
About PROCEPT BioRobotics
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH).
| Price | $84.30 |
| Target Price | Sign up |
| Volume | 396,360 |
| Market Cap | $4.56B |
| Year Range | $52.98 - $99.45 |
| Dividend Yield | 0% |
| Analyst Rating | 78% buy |
| Industry | Medical Devices |
In the news
 |
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Given Consensus Rating of “Moderate Buy” by BrokeragesJanuary 3 - ETF Daily News |
|
Stifel Financial Corp Sells 898 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT)December 28 - ETF Daily News |
|
HighTower Advisors LLC Purchases Shares of 3,486 PROCEPT BioRobotics Co. (NASDAQ:PRCT)December 24 - ETF Daily News |
|
Brokerages Set PROCEPT BioRobotics Co. (NASDAQ:PRCT) Price Target at $97.86December 11 - ETF Daily News |
|
Insider Selling: PROCEPT BioRobotics Co. (NASDAQ:PRCT) CEO Sells 26,423 Shares of StockDecember 9 - ETF Daily News |
|
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Stock Position in PROCEPT BioRobotics Co. (NASDAQ:PRCT)December 9 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 58M | 21M | 37M | -21M | -19M | -0.400 |
| Q2 '24 | 53M | 22M | 31M | -26M | -26M | -0.500 |
| Q1 '24 | 45M | 20M | 25M | -26M | -26M | -0.510 |
| Q4 '23 | 44M | 22M | 21M | -28M | -28M | -0.540 |
| Q3 '23 | 35M | 16M | 19M | -25M | -26M | -0.510 |
Insider Transactions View All
| Nouri Alaleh filed to sell 76,777 shares at $96.1. December 6 '24 |
| Nouri Alaleh filed to sell 52,472 shares at $97.9. December 6 '24 |
| Zadno Reza filed to sell 152,762 shares at $99. December 6 '24 |
| Zadno Reza filed to sell 154,997 shares at $98.1. December 6 '24 |
| Zadno Reza filed to sell 173,885 shares at $96.2. December 6 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$90.69 0% | 51 |
 |
Edwards LifesciencesEW |
$73.91 0% | 41 |
 |
Intuitive SurgicalISRG |
$535.3 0% | 71 |
 |
MedtronicMDT |
$80.95 0% | 50 |
 |
StrykerSYK |
$361.52 0% | 45 |
Read more about PROCEPT BioRobotics (PRCT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews & linkedin employees.
What is the Market Cap of PROCEPT BioRobotics?
The Market Cap of PROCEPT BioRobotics is $4.56B.
What is the current stock price of PROCEPT BioRobotics?
Currently, the price of one share of PROCEPT BioRobotics stock is $84.30.
How can I analyze the PRCT stock price chart for investment decisions?
The PRCT stock price chart above provides a comprehensive visual representation of PROCEPT BioRobotics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling PROCEPT BioRobotics shares. Our platform offers an up-to-date PRCT stock price chart, along with technical data analysis and alternative data insights.
Does PRCT offer dividends to its shareholders?
As of our latest update, PROCEPT BioRobotics (PRCT) does not offer dividends to its shareholders. Investors interested in PROCEPT BioRobotics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of PROCEPT BioRobotics?
Some of the similar stocks of PROCEPT BioRobotics are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.